Activity of allogeneic stem cell transplant day 100 [clinicaltrials_resource:36f9f2cb51a9b3a13434bbe318708af4]
Patients receive busulfan IV over 2 hours every 6 hours on days -7 to -4 and cyclophosphamide IV over 2 hours on days -3 and -2.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Activity of allogeneic stem cell transplant day 100 [clinicaltrials_resource:36f9f2cb51a9b3a13434bbe318708af4]
Patients receive busulfan IV over 2 hours every 6 hours on days -7 to -4 and cyclophosphamide IV over 2 hours on days -3 and -2.
Bio2RDF identifier
36f9f2cb51a9b3a13434bbe318708af4
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:36f9f2cb51a9b3a13434bbe318708af4
measure [clinicaltrials_vocabulary:measure]
Activity of allogeneic stem cell transplant
time frame [clinicaltrials_vocabulary:time-frame]
description
Patients receive busulfan IV o ...... ver 2 hours on days -3 and -2.
identifier
clinicaltrials_resource:36f9f2cb51a9b3a13434bbe318708af4
title
Activity of allogeneic stem cell transplant day 100
@en
type
label
Activity of allogeneic stem ce ...... 9f2cb51a9b3a13434bbe318708af4]
@en